Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $4.16 billion. The enterprise value is $3.91 billion.

Market Cap	4.16B
Enterprise Value	3.91B

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

SLNO has 52.79 million shares outstanding. The number of shares has increased by 50.95% in one year.

Current Share Class	52.79M
Shares Outstanding	52.79M
Shares Change (YoY)	+50.95%
Shares Change (QoQ)	+9.32%
Owned by Insiders (%)	1.40%
Owned by Institutions (%)	93.18%
Float	43.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	127.53
PS Ratio	110.00
Forward PS	35.08
PB Ratio	16.53
P/TBV Ratio	17.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	119.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.13, with a Debt / Equity ratio of 0.22.

Current Ratio	15.13
Quick Ratio	14.87
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-62.78

Financial Efficiency

Return on equity (ROE) is -69.53% and return on invested capital (ROIC) is -40.58%.

Return on Equity (ROE)	-69.53%
Return on Assets (ROA)	-36.60%
Return on Invested Capital (ROIC)	-40.58%
Return on Capital Employed (ROCE)	-59.84%
Revenue Per Employee	$354,967
Profits Per Employee	-$1.97M
Employee Count	92
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +68.44% in the last 52 weeks. The beta is -2.56, so SLNO's price volatility has been lower than the market average.

Beta (5Y)	-2.56
52-Week Price Change	+68.44%
50-Day Moving Average	82.19
200-Day Moving Average	62.49
Relative Strength Index (RSI)	37.05
Average Volume (20 Days)	1,252,159

Short Selling Information

The latest short interest is 5.87 million, so 11.11% of the outstanding shares have been sold short.

Short Interest	5.87M
Short Previous Month	5.35M
Short % of Shares Out	11.11%
Short % of Float	13.59%
Short Ratio (days to cover)	3.74

Income Statement

In the last 12 months, SLNO had revenue of $32.66 million and -$181.08 million in losses. Loss per share was -$3.97.

Revenue	32.66M
Gross Profit	31.96M
Operating Income	-186.32M
Pretax Income	-65.41M
Net Income	-181.08M
EBITDA	-184.31M
EBIT	-186.32M
Loss Per Share	-$3.97

Balance Sheet

The company has $286.84 million in cash and $52.77 million in debt, giving a net cash position of $241.07 million or $4.57 per share.

Cash & Cash Equivalents	286.84M
Total Debt	52.77M
Net Cash	241.07M
Net Cash Per Share	$4.57
Equity (Book Value)	240.14M
Book Value Per Share	4.76
Working Capital	295.85M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	97.87%
Operating Margin	-570.55%
Pretax Margin	-554.49%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.95%
Shareholder Yield	-50.95%
Earnings Yield	-4.36%
FCF Yield	n/a

Analyst Forecast

The average price target for SLNO is $110.22, which is 40.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$110.22
Price Target Difference	40.03%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Aug 26, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

SLNO has an Altman Z-Score of 13.13.

Altman Z-Score	13.13
Piotroski F-Score	n/a